VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.615
EU - Europa 1.553
AS - Asia 1.031
AF - Africa 219
SA - Sud America 207
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.635
Nazione #
US - Stati Uniti d'America 2.532
IT - Italia 617
SG - Singapore 538
CN - Cina 322
IE - Irlanda 291
BR - Brasile 189
UA - Ucraina 165
CI - Costa d'Avorio 136
DE - Germania 120
BE - Belgio 100
NL - Olanda 74
CA - Canada 71
RU - Federazione Russa 60
SN - Senegal 58
VN - Vietnam 51
GB - Regno Unito 45
IN - India 40
SE - Svezia 25
KR - Corea 18
CH - Svizzera 11
TR - Turchia 10
MX - Messico 8
NG - Nigeria 8
CZ - Repubblica Ceca 7
IR - Iran 7
UZ - Uzbekistan 7
BD - Bangladesh 6
FI - Finlandia 6
PL - Polonia 6
AR - Argentina 5
AU - Australia 5
FR - Francia 5
GR - Grecia 5
IQ - Iraq 5
MA - Marocco 5
EC - Ecuador 4
KE - Kenya 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
IL - Israele 3
JP - Giappone 3
PK - Pakistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
KZ - Kazakistan 2
RO - Romania 2
TW - Taiwan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.635
Città #
Santa Clara 479
Chandler 373
Singapore 343
Chicago 300
Dublin 290
Jacksonville 160
Civitanova Marche 145
Abidjan 136
Catania 125
Boardman 123
Andover 75
Cambridge 75
Lawrence 75
Grafing 73
Ashburn 72
Nanjing 71
Dakar 58
Rotterdam 53
Toronto 51
Wingene 50
Quintano 41
Wilmington 40
Dong Ket 39
Des Moines 38
Hefei 36
Houston 35
Brussels 31
San Mateo 30
Agrigento 29
The Dalles 26
Beijing 24
Columbus 23
Nanchang 21
Paternò 21
Council Bluffs 20
Hebei 19
Munich 19
Los Angeles 18
Kochi 17
Seoul 17
Ottawa 15
Saint Petersburg 15
São Paulo 15
Bremen 14
Jiaxing 14
Shenyang 12
Tianjin 12
Changsha 11
Nijmegen 11
Izegem 9
Abuja 8
Hanoi 8
Manchester 8
Pune 8
Ardabil 7
Bari 7
Gravina di Catania 7
Guangzhou 7
Jinan 7
Seattle 7
Zhengzhou 7
Brno 6
Knoxville 6
Kunming 6
London 6
New York 6
Redmond 6
Redwood City 6
Reggio Emilia 6
San Francisco 6
Valledolmo 6
Boston 5
Edinburgh 5
Falls Church 5
Leawood 5
Messina 5
Moscow 5
Mumbai 5
New Delhi 5
Palermo 5
Pescara 5
Rome 5
Stockholm 5
Aci Castello 4
Amsterdam 4
Antea 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Brasília 4
Bronte 4
Campinas 4
Curitiba 4
Hangzhou 4
Milan 4
Ningbo 4
Phoenix 4
Plymouth 4
Rio de Janeiro 4
Temse 4
Totale 4.068
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 191
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 119
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 118
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 104
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 100
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 96
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 93
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 90
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 89
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation 89
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 87
Comparative proteomic analysis of insulin receptor isoform A and B signaling 86
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 86
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 85
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 85
Insulin receptor isoforms in physiology and disease: An updated view 81
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 80
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 80
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 80
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 79
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 78
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 77
PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis 76
Insulin resistance: Any role in the changing epidemiology of thyroid cancer? 75
The IGF system in thyroid cancer:new concepts 74
BRAF(V600E) mutation and the biology of papillary thyroid cancer 73
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 73
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 73
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 72
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 71
p53 family proteins in thyroid cancer 69
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 69
Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study” 69
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 68
Abstract 4612: In breast cancer cells IGF-I induces upregulation of DDR1 by suppressing miR-199a-5p via the PI3K/Akt pathway 68
p73 tumor-suppressor activity is impaired in human thyroid cancer 67
Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study 67
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 66
Insulin receptor isoforms in cancer 66
Metabolic alterations of thyroid cancer as potential therapeutic targets 66
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 66
The p53-homologue p63 may promote thyroid cancer progression 65
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 65
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 63
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 63
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 62
The emerging role of insulin receptor isoforms in thyroid cancer: Clinical implications and new perspectives 62
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 62
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 61
Thyrospheres an in vitro model for human thyroid carcinogenesis 61
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 61
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 61
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 61
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 61
Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection 59
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 58
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 56
COVID-19 and Diabetes: The Importance of Controlling RAGE 56
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 56
Type 3 deiodinase: Role in cancer growth, stemness, and metabolism 56
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 55
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 55
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 54
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 54
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 52
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 50
Editorial: Early diagnoses and treatments of uncommon breast cancers 49
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 49
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 49
Role of BRAF(V600) mutation in the resistance to gefinitib of thyroid cancer cells. 49
Editorial: Resistance to Endocrine Therapies in Cancer 48
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 46
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 46
REGULATION OF mirRNAS BY p53 FAMILIY MEMBERS IN THYROID CANCER CELLS 45
Long-acting insulin analogs and cancer 45
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 43
EGFR INHIBITION ENHANCES THE SENSITIVITY OF POORLY DIFFERENTIATED THYROID CANCER CELLS TO CHEMOTHERAPY 43
REACTIVATION OF P53 MUTANTS BY SMALL COMPOUNDS MAY REPRESENT AN ADJUVANT THERAPY OF POORLY DIFFERENTIATED THYROID CANCER 42
Levels of histone acetylation in thyroid tumors 42
P63 EXPRESSION AND FUNCTION IN THYROID CANCER 41
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 40
Manuale di endocrinologia geriatrica 39
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 37
Identification of Thyroid Cancer Stem Cells 37
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 34
Short-term adverse affects of anticancer drugs in type 2 diabetes patients. 31
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 29
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 27
Metyrapone restores nocturnal cortisol profile and impaired post-dexamethasone suppression in mild autonomous cortisol secretion due to bilateral adrenal incidentaloma 18
Editorial: A year in review: discussions in cancer endocrinology 15
Totale 5.814
Categoria #
all - tutte 21.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021441 7 28 33 2 98 7 43 12 105 9 57 40
2021/2022555 49 91 15 7 82 3 82 29 42 0 17 138
2022/20231.252 82 43 36 155 124 182 34 230 269 24 40 33
2023/2024639 22 124 24 53 19 134 7 67 13 26 87 63
2024/20252.285 109 434 103 216 419 233 73 74 171 143 177 133
2025/202698 98 0 0 0 0 0 0 0 0 0 0 0
Totale 5.814